Weight-Loss Drugs Are Gobbling Up Small Town Budgets

Summary

---

Podcast Summary: The Journal.

Episode Title: Weight-Loss Drugs Are Gobbling Up Small Town Budgets
Date: June 29, 2026
Hosts: Imani Moiz (guest host), Ryan Knutson
Produced by: Wall Street Journal & Spotify Studios

---

Episode Overview

This episode delves into how small towns across America are being financially strained by the soaring costs of GLP1 weight-loss drugs, such as Ozempic and Wegovy, prescribed to municipal employees. Through the story of Belchertown, Massachusetts, and insights from WSJ economics reporter Owen Tucker Smith, the episode explores the difficult choices local governments are being forced to make—between maintaining basic town infrastructure and funding health care benefits.

---

Key Discussion Points and Insights

1. The Shockwave in Belchertown, MA

• Setting the scene: Belchertown, a picturesque small town of 15,000 outside Boston, had finally saved enough for essential infrastructure fixes after years of austerity.
• Sudden crisis: The Select Board received an unexpected bill of $900,000 in additional health insurance premiums due to a spike in GLP1 drug prescriptions for weight loss among employees.
  • Quote:

    "I was shocked. I was absolutely shocked. And my first reaction is, how can they do that?"
    — Lisa Lassard Pearson, Select Board Member [01:34]

• Aftermath: The town had to immediately decide between healthcare obligations and critical infrastructure upkeep.
• Community response: Residents, already reeling from a recent tax hike, were incensed by the sudden drain on resources.

2. Why Are GLP1 Drug Costs Hitting Small Towns Hard?

• Limited budgets: For small towns, even a modest uptick in high-cost prescriptions can create massive budget holes.
  • Quote:

    "...all it takes is a few dozen people to be on these drugs for costs to start potentially rising quite quickly."
    — Ryan Knutson [05:00]

• Rapid growth in usage: National survey data showed a doubling in GLP1 drug use among Americans for weight loss within a year.
• Unpredictable impact: Health insurance trusts pooling multiple towns saw costs surge unexpectedly, threatening insolvency.

3. The Hard Choices: Town Budgets vs. Employee Health

• Budget trade-offs:
  • Planned repairs and upgrades (senior center, school lighting) were put on ice.
  • Both town operations and schools clawed back already-allocated funds, freezing hires and drawing on reserves.
    • Quote:

      "There's a laundry list of needs...some of them may seem insignificant, but it's a game changer."
      — Lisa Lassard Pearson [09:45]

• Collective action: Town boards, school committees, and finance committees united to share the pain and formulate a community-wide solution.
  • Quote:

    "It was very loving... we all needed to pitch in, all needed to give things up."
    — Lisa Lassard Pearson [10:45]

4. The Dilemma Spreads: Other Towns and States Grapple

• Comparison: In Duxbury, MA, 7% of plan members accounted for 25% of pharmacy claims—mostly from GLP1 prescriptions [13:18].
• State-level debates: Massachusetts state employee health programs also weighed whether to keep covering the drugs.
• Two sides to the argument:
  • Supporters: Argue that treating obesity addresses underlying issues, potentially lowering long-term costs.
    • Quote:

      "If we vote to eliminate GLP1s, we're cutting off treatment while we keep paying for everything else..."
      — State insurance board member [14:00]

  • Skeptics: Concerned that drugs are used for cosmetic reasons, manipulating the system and straining taxpayer funds.
• Impossible choices:
  • Town leaders face harsh negotiations: higher wages or the same level of healthcare coverage?
    • Quote:

      "...he has to bring these questions to employees like: do you want a raise or do you want the same level of health care? And that's where some of these towns are at."
      — Ryan Knutson [15:25]

5. Uncertainty and Search for Solutions

• Data gap: The long-term value of covering these expensive medications is still unproven.

  • Quote:

    "It's not one where they have a ton of data to use to make that decision. Besides the fact that the costs are up because, again, the drugs are new enough that it's really hard to say what is worth it and what isn't."
    — Ryan Knutson [16:04]

• Experimenting with coverage: Some towns restrict coverage to generics or require participation in monitored weight-loss programs [16:53].

6. The Result: Belchertown Forced to Drop Coverage

• Final decision: Belchertown’s insurance trust stops covering GLP1s for weight loss (but keeps coverage for diabetes care) [17:14].

7. The Call for Greater Support

• Lisa Lassard Pearson: Urges state and federal governments to step in—pharmaceutical pricing and lack of federal support put small towns at risk of decline.

  • Quote:

    "We need to rein in pharmaceutical spending, and the government needs to step in and help small communities like ours...We want towns. We think towns are very important to continue to thrive, not just survive."
    — Lisa Lassard Pearson [17:44]

• Final reflection: The episode ends on a poignant note about the value of small towns and the consequences if their needs keep going unmet.

  • Quote:

    "...if the government and pharmaceutical companies don't start getting more real and realistic about their pricing, and also political officials don't get more serious about protecting small towns in America, then we could lose them. And I don't even know what that world would look like, especially in this country."
    — Lisa Lassard Pearson [18:25]

---

Notable Quotes & Memorable Moments

• “This isn't like fun, sexy projects. This is...the real work stuff that needs to be done to keep the town going.”
  — Lisa Lassard Pearson, on deferred repairs [00:50]
• “After all the careful planning we had done and the months we spent working on the budget, it was devastating.”
  — Lisa Lassard Pearson [02:06]
• "Some of them are saying, we'll cover this, but you have to go on this strict kind of weight loss plan where we're monitoring your success. And so there's a lot of different solutions that are emerging here."
  — Ryan Knutson [16:53]

---

Timestamps for Key Segments

• 00:11–02:29: Belchertown’s budget surprise and the impact of the $900,000 invoice
• 04:54–06:35: National trend—GLP1s driving unsustainable increases in small-town health spending
• 07:12–08:29: How insurance trusts spread, but can't absorb, these sudden costs
• 09:12–10:40: Specific sacrifices made by Belchertown: school and municipal cutbacks
• 12:54–13:50: Duxbury’s similar struggle discussed in a public town meeting
• 14:00–15:25: The wider debate on coverage—wellness vs. budget, compassion vs. cost
• 16:04–17:14: The lack of long-term data and towns' makeshift adjustments to coverage
• 17:14–17:44: Belchertown drops GLP1 coverage for weight loss; federal help needed
• 18:25–19:25: Final reflections on the bigger implications for America’s small towns

---

Tone and Language

The tone is urgent, communal, and at times both frustrated and compassionate. Town leaders and journalists alike speak plainly about the hard reality: “What are we supposed to cut—health or schools?” The discussions reflect the small-town ethos of everyone pitching in, but also an undercurrent of anxiety and worry about the future of America's towns under impossible financial pressure.

---

This episode provides a vivid, human look at a complex economic and social dilemma, offering both the granular details and the big-picture stakes of small-town America’s struggle with soaring healthcare costs.

Transcript

[Ryan]

Hey, it's Ryan. Our colleague Imani Moiz is here to

[Imani Moiz]

guest host today's episode.

[Lisa Lassard Pearson]

Here it is.

[Imani Moiz]

About an hour outside of Boston, there's a picturesque small town surrounded by forested hills called Belchertown. That's where Lisa Lassard Pearson lives.

[Lisa Lassard Pearson]

My spouse and I affectionately call it Belcher Town, or B Town. To get around the the Belchertown connotations,

[Imani Moiz]

Lisa sits on something called the Select Board. It's a small town version of a city council that serves Belchertown's 15,000 people. And after years of saving up reserves, the townhead finally scraped together enough money for a few key infrastructure projects, like repairing the roofs and the lights at the schools and updating the senior center.

[Lisa Lassard Pearson]

These are basics. This isn't like fun, sexy projects. This is like the real work stuff that needs to be done to keep the town going.

[Imani Moiz]

But then came a surprise invoice.

[Lisa Lassard Pearson]

I got a phone call from the town manager. It came to him first, and he immediately reached out to me.

[Imani Moiz]

The bill was from the town's health insurance administrator. It said Belchertown owed an additional $900,000 in health insurance premiums, which is a

[Lisa Lassard Pearson]

major fiscal event for a town our size.

[Imani Moiz]

What was going through your mind at first when you saw these numbers?

[Lisa Lassard Pearson]

I was shocked. I was absolutely shocked. And my. My first reaction is, how can they do that?

[Imani Moiz]

At first, the board didn't even know what they were being charged for. But eventually they learned that their health insurance administrator was facing massive deficits. A major cause, the growing use of GLP1 weight loss drugs.

[Lisa Lassard Pearson]

After all the careful planning we had done and the months we spent working on the budget, it was devastating.

[Imani Moiz]

Belchertown had no choice but to pay up, which meant it was faced with a big budget question. What's more important, healthcare or keeping the lights on?

[Lisa Lassard Pearson]

I mean, what I want to really say is Belchertown is not unique. Belchertown's just a, as I say in Boston, wicked good example of, you know, what can happen to a small town.

[Imani Moiz]

Welcome to the Journal, our show about money, business and power. I'm Imani moise. It's Monday, June 29th. Coming up on the show, how small towns are tightening their belts to cover weight loss drugs. This episode of the Journal is brought to you by Harvey, an AI platform designed for legal and professional services. Built and tested by lawyers, Harvey is trusted by more than 60% of the AmLaw100. The platform dramatically reduces time spent on research, drafting, and document review without sacrificing quality, all while meeting the highest industry standards for Security and Compliance Harvey AI Tailored for Law. Visit Harvey AI to learn more and request a demo.

[Indeed Sponsor Voice]

This episode is brought to you by Indeed. The right hire can make or break your company, especially if you're a small business. And relying on luck to find that person isn't really the best strategy. But you know what is using Indeed Sponsored Jobs. You can use it to boost your job post to make sure it reaches more people with the right talents, certification, location and more. So Sponsored jobs posted directly on indeed are 95% more likely to report a hire than non Sponsored Jobs. Spend less time searching and more time actually interviewing candidates who check all your boxes. Less stress, less time, more results when you need the right person to cut through the chaos. This is a job for Indeed Sponsored Jobs and listeners of this show will get a $75 sponsored job credit to help get your job the premium status it [e-mail] podcast.com just go to indeed.com podcast right now and support the show by saying you heard about indeed here indeed.com podcast terms and conditions apply. Hiring now then this is a job for Indeed Sponsored Jobs.

[Imani Moiz]

Across the country, the cost of weight loss drugs for small town employees is starting to break the bank.

[Ryan]

Because for a small town of, you know, thousands of people versus millions of people, you know, all it takes is a few dozen people to be on these drugs for costs to start potentially rising quite quickly.

[Imani Moiz]

We called up our colleague Owen Tucker Smith, who answered from a hotel room in Missouri.

[Ryan]

I am on the economics team here at the Journal, so we were always roaming around the country looking for interesting economic stories, you know, towns and interesting conundrums like for this story, a lot

[Imani Moiz]

of these towns were already operating on super tight budgets, just enough to cover basics like payroll and electricity.

[Ryan]

And so when you start to see costs rising by $100,000, it's something that might not, you know, be too problematic for a big city, but for some of these towns, that can really change the calculus of what they are and are not able to afford.

[Imani Moiz]

So why did this issue catch so many towns by surprise?

[Ryan]

Yeah, so towns knew at the beginning that GLP1 drugs were gaining tract, but I think very few of them realized exactly how popular they were going to

[Imani Moiz]

be or how expensive. Even after recent price cuts, these drugs can still cost insurers hundreds of dollars a month for each patient. Meanwhile, they're being prescribed more and more. According to Gallup polling, more than 12% of Americans reported taking GLP1 drugs for weight loss last fall. That's twice as much as the year

[Ryan]

before the utilization of them has skyrocketed. And in a lot of these kind of audit reports that the towns talk about, they were getting notes from their health insurance brokers just saying that the usage of these drugs had doubled or tripled or more over the course of a few years. And when you have a pretty expensive drug that goes up so much so quickly in usage, it can kind of catch you off guard. And I think that's what happened with a lot of these towns.

[Imani Moiz]

The health insurance that these small towns are paying for covers their municipal employees like teachers, firefighters, police officers, and sanitation workers, Jobs that don't always come with the highest salaries, but tend to have great benefits.

[Lisa Lassard Pearson]

To attract workers, municipal government basically takes care of the town in all its many facets.

[Imani Moiz]

Lisa's town gets health insurance for its municipal workers through a regional trust called Hampshire County Group Insurance Trust.

[Ryan]

It's sort of a pool of towns that are. They're too small to have their own health insurance, so they all kind of pool together to sort of balance out the risks across the towns. But one commonality between all of these towns, including Belchertown, was that GLP1 costs and usage were going way up.

[Imani Moiz]

Costs were going up so much that the trust was on the verge of insolvency. The Trust said that GLP1s for weight loss were a significant contributor to their financial problems.

[Ryan]

And so they reached out to all of the towns and gave them the background. We're losing a lot of money every year because of this, and we're going to need you guys to pay in the middle of the year, which is really unusual for this trust to just keep us afloat.

[Imani Moiz]

Lisa said news of the surprise bill didn't sit well with her community. Belchertown had already decided to raise taxes on its residents two months before. And now this for the town.

[Lisa Lassard Pearson]

They were up in arms. I mean, you know, they had their torches and. And they blamed the executive board, they blamed the finance committee and the town manager for, quote, unquote, not seeing that this was going to happen. Somehow we were supposed to forecast this. So this was very unwelcome news.

[Imani Moiz]

Lisa said the board went into damage control mode.

[Lisa Lassard Pearson]

We worked as a tri board, bringing in the school committee, the finance committee, and the select board to work collectively on developing a solution. And that's about the only magical thing that happened. This was a community problem that we were going to solve, and we were going to do it together.

[Imani Moiz]

That solution came with big sacrifices.

[Lisa Lassard Pearson]

There's a laundry list of needs, including shoring up our senior center and lighting at one of our schools. Some of them may seem insignificant, but it's a game changer.

[Imani Moiz]

Not only did the town have to put planned projects on hold, they also had to claw back money already allocated for other things.

[Lisa Lassard Pearson]

The town was able to give some money back. The schools also gave some of their money back. This is from their own budgets and positions that were going to be hired were put on hold and obviously we gave a lot from our reserves.

[Imani Moiz]

You said that the schools had to give money back. How did that go over?

[Lisa Lassard Pearson]

It was a very, it was very loving and that's an odd way of putting it right. But everyone at the table understood that this was a community decision and we all needed to pitch in, all needed to give things up. And I'm very proud of the way Belchertown handled this problem. But we're not out of the woods yet. Could something like this happen again? Yes,

[Imani Moiz]

Belchertown figured out how to cover the surprise bill, but they still had to figure out if they'd keep covering GLP1s in the future. That's next. This episode is brought to you by Optum. Healthcare doesn't always work great. If you ever waited on a refill or couldn't schedule an appointment, you get it. That's what Optum is changing. They're using data and technology to integrate patient care, pharmacy and everything else. So healthcare is connected, not complicated. That means cheaper prescriptions that are easier to get and care that looks at the whole person how you need it. Optum is making healthcare work as one for everyone. Learn more business.optum.com this message is brought

[Ryan]

to you by Mariner. You've built your book. You've built your reputation.

[Imani Moiz]

Now you're ready to build more. With Mariner, you're ready to experience less friction and grow with more momentum.

[Ryan]

You're ready for a model designed to

[Imani Moiz]

help you spend more time with clients. You're ready for the green light to advise your way.

[Ryan]

You're ready for Mariner Financial planning, management and solutions. Take the next step in your career@join mariner.com.

[Lisa Lassard Pearson]

First item on the agenda is the Pledge of Allegiance.

[Imani Moiz]

Pledge allegiance to the flag of the United States of America. A couple hours from Belchertown is another town called Duxbury. Back in April, they held a community meeting at their town hall in what's called the Mural Room. Members of the Select Board sat behind a desk facing their neighbors. A painting of the town in its early days with horse drawn wagons and wooden sailing ships filled the wall behind them.

[Lisa Lassard Pearson]

In calendar year 2025, Duxbury had 7% of its members account for 25% of total pharmacy claims related to GLP1s prescribed for weight loss alone.

[Imani Moiz]

They were gathered to discuss GLP1 coverage for town employees.

[Ryan]

Our razor thin budget. Everybody in this community is well aware of where we're at as a community. What they aren't totally aware of, maybe until they bore down on the details, is this is the big driver in our budget.

[Imani Moiz]

You have to sympathize with people. There has to be compassion. This debate isn't just happening in small towns. Massachusetts also had to consider changing benefits for state employees. Here's a meeting the state insurance provider held in February. So when a doctor prescribes a GLP1 for weight loss in these patients, they're treating the root cause of heart disease and hypertension, which we're paying to manage. Supporters say GLP1 coverage for weight loss will pay off over time. If we vote to eliminate GLP1s, we're cutting off treatment while we keep paying for everything else. The cardiac drugs, the blood pressure medications, the ER visits, hospitalizations. But others worry that the drugs are being used for cosmetic improvements that shouldn't be paid for with taxpayer dollars. I could go to my physician because of my relationship with my physician and ask that physician to give me a GLP1 drug and really exaggerate something that I may or may not have. And that's human nature. You sort of manipulate the system and they're faced with the reality that at the end of the day, small town budgets are only so big. It's a very difficult decision and one that's in front of us from a budget perspective, which we also have a responsibility to balance.

[Ryan]

I think it's for a lot of these towns, an impossible decision. You're going to get blowback either way. And in fact, I spoke to one town manager in Massachusetts who was, you know, going into negotiations with the union and he said he's going to have to, you know, he has to bring these questions to employees like do you want a raise or do you want the same level of health care? And that's where some of these towns are at. No one really wants to have to make that decision.

[Imani Moiz]

And there's not yet enough research about the long term benefits to be sure.

[Ryan]

It's not one where they have a ton of data to use to make that decision. Besides the fact that the costs are up because again, the drugs are new enough that it's really hard to say what is worth it and what isn't. Especially when, you know you're getting conflicting opinions, even from academics and economists on this issue. There's also this sort of sense of almost helplessness, of just like the decisions we have to make right now is not, you know, how do we make these drugs less expensive? It's we have to decide how we're gonna pay, like, what teacher positions we're going to cut, where we're gonna find the money to hire this new firefighter, et cetera.

[Imani Moiz]

Some towns are opting to tweak coverage as a sort of compromise.

[Ryan]

Some are saying, you know, maybe we'll cover the generic brand, but not this brand. Some of them are saying, we'll cover this, but you have to go on this strict kind of weight loss plan where we're monitoring your success. And so there's a lot of different solutions that are emerging here.

[Imani Moiz]

As for Belchertown, their insurance trust ultimately decided to stop covering GLP1s for weight loss.

[Ryan]

In many cases, they're retaining coverage for diabetes, just not for weight loss. And for many of those areas, there's plenty of employees who are going to lose access when the fiscal year turns over.

[Imani Moiz]

Lisa says she hopes the state or federal government will step in to help ease the financial strain of these drug costs.

[Lisa Lassard Pearson]

We need to rein in pharmaceutical spending, and the government needs to step in and help small communities like ours. We don't have the largest that, you know, big cities do, and we want towns. We think towns are very important to continue to thrive, you know, not just survive.

[Imani Moiz]

So what do you think is the best way to use a town budget to serve the town? Is it roads, schools, buildings, or health care?

[Lisa Lassard Pearson]

It's all of them, obviously. You know, we need all those just like any other community. Like, what would you take out of that equation? And if the government and pharmaceutical companies don't start getting more real and realistic about their pricing, and also political officials don't get, you know, more serious about protecting small towns in America, then we could lose them. And I don't even know what that world would look like, especially in this country.

[Imani Moiz]

That's all for today. Monday, June 29th. The Journal is a co production of Spotify and the Wall Street Journal. Additional reporting in this episode by Heather Haddon, Amira McKee and Nicholas G. Miller. Thanks for listening. See you tomorrow. This episode is brought to you by Google Chrome. You think you know a browser, but Gemini and Chrome, that's new. It can help you with practically anything on the web, like restoring a vintage motorcycle from a 50 page restoration block or finally break down that long article you've had open for weeks. Gemini and Chrome is here for it, ready to make anything online make sense. There's no place like Chrome. Check responses set up required compatibility and availability various 18.